MGNX
MacroGenics, Inc.
MGNX trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over MGNX overall, supported by lower modeled downside and stronger modeled upside.
MGNX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
MGNX's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MGNX PE Valuation
MGNX has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MGNX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect MGNX's losses to grow, with revenue declining. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MGNX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.82 | +$0.37 |
| Q2 2026 | -$0.23 | +$0.33 |
| Q1 2026 | -$1.11 | -$0.23 |
| Q4 2025 | -$1.18 | -$0.11 |
| Q3 2025 | -$1.19 | +$0.38 |
| Q2 2025 | -$0.56 | +$1.63 |
| Q1 2025 | -$0.88 | -$0.50 |
| Q4 2024 | -$1.07 | -$0.92 |
MGNX is still losing money, but far less than before: $0.82 per share over the past year, against $3.56 at its worst in mid-2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MGNX on earnings quality, reporting a profit while its opponent remains loss making.
MGNX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7M | -74% |
| Q2 2026 | $32.8M | +48% |
| Q1 2026 | $20.8M | +57% |
| Q4 2025 | $41.2M | +113% |
| Q3 2025 | $72.8M | -34% |
| Q2 2025 | $22.2M | +106% |
| Q1 2025 | $13.2M | +45% |
| Q4 2024 | $19.4M | +81% |
MGNX's revenue has slid since its 2024 peak: $19M last quarter, down 74% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -109% | -134 points |
| Q2 2026 | -42% | +123 points |
| Q1 2026 | -161% | +162 points |
| Q4 2025 | -29% | +244 points |
| Q3 2025 | 26% | -23 points |
| Q2 2025 | -165% | +374 points |
| Q1 2025 | -323% | +267 points |
| Q4 2024 | -273% | +187 points |
MGNX's operating margin was −109% last quarter, down 134 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MGNX on profitability, with a higher operating margin.
MGNX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.4M | +$24.2M |
| Q2 2026 | -$41.6M | +$6.1M |
| Q1 2026 | -$36.2M | +$11.3M |
| Q4 2025 | $42.8M | +$81.8M |
| Q3 2025 | -$30.6M | -151% |
| Q2 2025 | -$47.7M | -$2.2M |
| Q1 2025 | -$47.4M | -$317K |
| Q4 2024 | -$39M | -$10.4M |
MGNX has burned cash in almost every quarter: −$41M over the past year, against −$165M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over MGNX on cash generation, producing positive trailing cash flow while its opponent burns cash.
MGNX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +149K shares |
| 1 year | +0.7% | +460K shares |
| 3 years | +2.4% | +1.5M shares |
| 5 years | +4.2% | +2.6M shares |
| Available history | +33% | +15.7M shares |
MGNX has 64M diluted shares, up 0.7% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over MGNX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MGNX Net Leverage
MGNX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MGNX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 16.0 | Oversold |
MGNX's weekly RSI is 35 (neutral) and its Stochastic is 16 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MGNX PE vs Healthcare Sector
| Metric | MGNX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
MGNX has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
MGNX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.95 | 22% below |
| 20 week MA | $3.68 | 38% below |
| 50 week MA | $3.11 | 26% below |
| 100 week MA | $2.51 | 8.8% below |
| 200 week MA | $4.78 | 52% below |
MGNX is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MGNX on trend strength, trading above more of its moving averages.
MGNX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.8 | $24.3 | +126% |
| 2021 | $24.3 | $17.4 | -28% |
| 2022 | $17.4 | $5.94 | -66% |
| 2023 | $5.94 | $9.62 | +62% |
| 2024 | $9.62 | $3.23 | -66% |
| 2025 | $3.23 | $1.61 | -50% |
| 2026 YTD | $1.61 | $2.29 | +42% |
MGNX has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.